LEGISLATIVE FISCAL OFFICE
Fiscal Note
Fiscal Note On: SB 48 SLS 24RS 178
Bill Text Version: ENGROSSED
Opp. Chamb. Action:
Proposed Amd.:
Sub. Bill For.:
Date: April 7, 2024 1:46 PM Author: TALBOT
Dept./Agy.: Insurance and Office of Group Benefits
Subject: Consensus Statements for Biomarker Testing, Penalties Analyst: Patrice Thomas
GENETICS EG NO IMPACT See Note Page 1 of 1
Provides for health insurance coverage of genetic testing for diseases and other medical conditions. (gov sig)
Present law requires health plans to cover biomarker testing for diagnosis, treatment, appropriate management, or ongoing
monitoring. Present law provides a list of items demonstrated by medical and scientific evidence that biomarker testing
provides clinical utility. Proposed law repeals the requirement of a specific appropriation before present law becomes
effective and provides an effective date of January 1, 2025 for all health plans issued.
EXPENDITURES 2024-25 2025-26 2026-27 2027-28 2028-29 5 -YEAR TOTAL
State Gen. Fd. $0 $0 $0 $0 $0 $0
Agy. Self-Gen. $0 $0 $0 $0 $0 $0
Ded./Other $0 $0 $0 $0 $0 $0
Federal Funds $0 $0 $0 $0 $0 $0
Local Funds $0 $0 $0 $0 $0 $0
Annual Total $0 $0 $0 $0 $0 $0
REVENUES 2024-25 2025-26 2026-27 2027-28 2028-29 5 -YEAR TOTAL
State Gen. Fd. $0 $0 $0 $0 $0 $0
Agy. Self-Gen. $0 $0 $0 $0 $0 $0
Ded./Other $0 $0 $0 $0 $0 $0
Federal Funds $0 $0 $0 $0 $0 $0
Local Funds $0 $0 $0 $0 $0 $0
Annual Total $0 $0 $0 $0 $0 $0
EXPENDITURE EXPLANATION
There is no anticipated direct material effect on governmental expenditures as a result of this measure. Proposed law repeals
the provision of specific appropriation and provides for an effective date of January 1, 2025, for all new health plans issued
on or before the date. The Office of Group Benefits (OGB) reports no impact. The health actuary for the LA Department of
Insurance (LDI) estimates that there will be no material cost impact on the private insurance industry as a result of this
measure.
REVENUE EXPLANATION
There is no anticipated direct material effect on governmental revenues as a result of this measure.
Senate Dual Referral Rules House
13.5.1 >= $100,000 Annual Fiscal Cost {S & H} 6.8(F)(1) >= $100,000 SGF Fiscal Cost {H & S}
Alan M. Boxberger
13.5.2 >= $500,000 Annual Tax or Fee 6.8(G) >= $500,000 Tax or Fee Increase
Change {S & H} or a Net Fee Decrease {S} Legislative Fiscal Officer


Statutes affected:
SB48 Original: